Philadephia
Philadephia
Philadephia, Pennsylvania, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial to Increase FEP Attendance | First-Episode Psychosis | Active, not recruiting | Early phase 1 | 2026-10-06 | NCT05967195 | |
| Evaluating an Artificial Intelligence-Based Diagnostic Support Tool for Older Adults in Primary Care | Diagnostic Support | Not yet recruiting | Not applicable | 2026-09-23 | NCT07553559 | |
| Preoperative Opioid Tapering Before Spine Surgery | Chemically-Induced Disorders, Narcotic-Related Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, anxiety disorder, depressive disorder, nervous system disorder, opiate dependence, perceptual disorders, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-03-24 | NCT07221786 | |
| Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder | Active, not recruiting | Not applicable | 2026-01-07 | NCT05268094 | |
| Two Step Haplo With Radiation Conditioning | B-cell chronic lymphocytic leukemia, Blood Protein Disorders, Bone Marrow Failure Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, acquired polycythemia vera, acute myeloid leukemia, adult T-cell leukemia/lymphoma, anemia, aplastic anemia, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cardiovascular disorder, chronic myelomonocytic leukemia, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, myeloid neoplasm, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, primary myelofibrosis, thrombocytosis disease, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2025-10-30 | NCT05031897 |